SenesTech, Inc. (NASDAQ: SNES) announced the issuance of its patent on “REDUCING THE REPRODUCTIVE CAPACITY OF MAMMALS.” This intellectual property is a key aspect of ContraPest®, SenesTech’s flagship product that targets the reproductive capabilities of Norway and roof rats . The patent application was filed August 23, 2013, and has been issued on May 3, 2018 with patent number US 9,956,235.
Continue reading
Author Archive: AZBio
UA Surgeons Developing New Tool to Detect Urine Blockage
Surgeons at the University of Arizona College of Medicine – Tucson are developing a tool that may make detecting urine blockage simpler for patients.Continue reading
UA Health Sciences and UA Researchers Awarded ABRC Grants Totaling Nearly $6M for Health Research
The three-year Arizona Biomedical Research Commission Awards will fund research relating to neuropathic and cancer pain, migraines, opioids, antibiotics, antivirals, sinusitis, obesity, diabetes, Parkinson’s disease, pulmonary disease and pediatric acute-onset neuropsychiatric syndrome.Continue reading
Enzyme’s movement may be key to new cancer drugs
Interfering with the motion of a kinase enzyme might be a new approach for the development of anti-cancer drugsContinue reading
Brain Tumor Atlas Published in the Journal Science
Researchers around the world use publicly available Ivy Glioblastoma Atlas Project to investigate aggressive brain cancer
AZ-HCIF Featured in AZ Business Magazine
AZBio, OTEF, and the Healthcare Impact Foundation’s efforts to establish an endowment to support the commercialization of life science innovation in Arizona is featured in the May/June issue of AZ Business Magazine.Continue reading
Regenesis Biomedical Announces Initiation of a Clinical Trial on Subjects with Painful Diabetic Distal Symmetric Peripheral Neuropathy (DSPN)
Regenesis Biomedical, a Scottsdale-based medical device company, has initiated a multi-center, randomized clinical trial assessing the Provant® Therapy System for relieving symptoms of painful diabetic distal symmetric peripheral neuropathy (DSPN).Continue reading
Operating on brain gliomas by detecting the ‘glow’
Research by Barrow Neurological Institute physicians and University of Washington scientists on novel imaging technology for malignant brain tumors was published in the April issue of World Neurosurgery.Continue reading